For chronic refractory IC/BPS patients, AboBTXA was associated with no overall improvement in total OLS score, although significant benefit was noted in a small number of patients. The absence of posttreatment UTI was associated with a better response to AboBTXA.

No abstract

BackgroundDeath audits have been used to describe pediatric mortality in under-resourced settings, where record keeping is often a challenge. This information provides the cornerstone for the foundation of quality improvement initiatives. Malawi, located in sub-Saharan Africa, currently has an Under-5 mortality rate of 64/1000. Kamuzu Central Hospital, in the capital city Lilongwe, is a busy government referral hospital, which admits up to 3000 children per month. A study published in 2013 reported mortality rates as high as 9%. This is the first known audit of pediatric death files conducted at this hospital.MethodsA retrospective chart review on all pediatric deaths that occurred at Kamuzu Central Hospital (excluding deaths in the neonatal nursery) during a 13-month period was done using a standardized death audit form. A descriptive analysis was completed, including patient demographics, HIV and nutritional status, and cause of death. Modifiable factors were identified that may have contributed to mortality, including a lack of vital sign collection, poor documentation, and delays in the procurement or results of tests, studies, and specialist review.ResultsSeven hundred forty three total pediatric deaths were recorded and 700 deceased patient files were reviewed. The mortality rate by month ranged from a low of 2.2% to a high of 4.4%. Forty-four percent of deaths occurred within the first 24 h of admission, and 59% occurred within the first 48 h. The most common causes of death were malaria, malnutrition, HIV-related illnesses, and sepsis.ConclusionsThe mortality rate for this pediatric referral center has dramatically decreased in the 6 years since the last published mortality data, but remains high. Areas identified for continued development include improved record keeping, improved patient assessment and monitoring, and more timely and reliable provision of testing and treatment. This study demonstrates that in low-resource settings, where reliable record keeping is often difficult, death audits are useful tools to describe the sickest patient population and determine factors possibly contributing to mortality that may be amenable to quality improvement interventions.

The aim of this study was to compare functional gait differences between patients with myelomeningocele (MM) who have a ventriculoperitoneal shunt (VPS) with those who do not. Our analyses were adjusted for confounding by age, lesion level, orthotic use, and assistive device use. The Functional Mobility Scale (FMS) was used to compare the shunted group (n=98; 60 males, 38 females; mean age 10y 2mo [SD 3y 11mo]; 73 sacral/19 low lumber/six high lumbar lesion level) with the non-shunted group (n=63; 32 males, 31 females; mean age 9y 11mo [SD 3y 11mo]; 45 sacral/12 low lumber/six high lumbar lesion level). Participants with a shunt had lower FMS 500 and FMS 50 scores compared with participants without a shunt; hence the participants without a shunt were more independent in their ambulation at medium and longer distances. For a subset of participants who underwent a three-dimensional gait analysis, we also collected temporal-spatial gait parameters (velocity, cadence, and stride length). Our results show that participants with MM and no shunt who underwent gait analysis(11 males, 10 females; mean age 9y 6mo [SD 4y]; 15 sacral/6 low lumber/0 high lumbar lesion level) tend to walk at a significantly greater velocity and stride length as compared with those with a shunt (33 males, 18 females; mean age 10y [SD 4y]; 38 sacral/13 low lumber/zero high lumbar lesion level). These data allow the treatment team to present more specific information regarding functional ambulatory expectations to patients with MM and their families.Hydrocephalus is an abnormal accumulation of cerebrospinal fluid in the ventricular system as a result of an obstruction and occurs in approximately 85 to 90% of patients with myelomeningocele (MM). 1-3 Several pathophysiological mechanisms may cause hydrocephalus in patients with MM. All have potentially a common origin in the Chiari II caudal hindbrain anomaly that is present in virtually all patients with MM. [1][2][3] Hydrocephalus is often treated with a ventriculoperitoneal shunt (VPS). Two possible strategies towards the timing of VPS placement include immediate VPS placement and delayed VPS placement. In the first strategy, if observable hydrocephalus is present, the neurosurgeon recommends repairing the MM and placing the VPS during the initial newborn admission. [3][4][5][6] A second strategy is for the VPS placement to be performed post-MM repair if the clinical signs and symptoms of hydrocephalus are found to be progressive. 1,7 Up to 50% of all shunted children with MM will require multiple shunt revisions 8 and shunt malfunction and complications remain an important cause of morbidity and mortality in patients with MM. 5,[9][10][11][12][13] Studies have related significant factors for successful functional outcomes in patients with MM, such as cognitive status, muscle strength, and lesion level; 14-17 however, the effect of shunting on mobility has not been determined. The purpose of conducting this study is to provide families and members of the spina bifida treatment team with more de...

No abstract